A Randomized, Placebo-Controlled Clinical Trial of Tacrolimus Ophthalmic Suspension 0.1% in Severe Allergic Conjunctivitis

AIMS: To examine the efficacy of tacrolimus ophthalmic suspension 0.1% in treating severe allergic conjunctivitis. METHODS: This was a multicenter, randomized, double-masked, placebo-controlled clinical trial. Fifty-six patients with severe allergic conjunctivitis in whom topical antiallergic agents...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ohashi, Yuichi, Ebihara, Nobuyuki, Fujishima, Hiroshi, Fukushima, Atsuki, Kumagai, Naoki, Nakagawa, Yayoi, Namba, Kenichi, Okamoto, Shigeki, Shoji, Jun, Takamura, Etsuko, Hayashi, Kunihiko
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Mary Ann Liebert, Inc. publishers 2010
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3158389/
https://ncbi.nlm.nih.gov/pubmed/20307214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2009.0087
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items